DNMT3B and ovarian carcinoma: Qiu et al. demonstrated that increased DNMT3A and DNMT3B gene expression correlates with cisplatin resistance in murine neuroblastoma cells, while platinum resistance remains a major obstacle in ovarian cancer treatment with Carboplatin or cisplatin, emphasizing the need for further exploration of the underlying molecular mechanisms [61,62].